Recognition and Validation of Druggable Targets from the Response to Cognitive Behaviour Therapy in Myotonic Dystrophy type 1 patients from Integrated -Omics Networks Ghent University
Myotonic dystrophy type 1 (DM1), the most common adult form of muscular dystrophy,
affects virtually all tissues; the noncurable condition carries significant morbidity and
mortality impacting patient and family quality of life and socio-economic status. The
OPTIMISTIC clinical trial has shown that Cognitive Behaviour Therapy (CBT), a patienttailored
intervention to increase activity and enable ...